EP Vantage Wins Commentator of the Year Award at European Mediscience Awards 2011
LONDON, June 24, 2011 /PRNewswire/ –
EP Vantage, part of EvaluatePharma, was presented with the coveted
Commentator of the Year Award at the European Mediscience Awards, sponsored
by Matrix, on June 22, 2011.
The award, which honours clear and concise commentary in the pharma and
biotech sector, can be given to analysts, journalists, columnists, research
houses or specialist websites dedicated to providing sharp, perceptive and
The EP Vantage team – Lisa Urquhart, Amy Brown, Christian Glennie and
Jonathan Gardner – beat a strong field that included analysts and fellow
journalists to claim the prize.
Speaking about the achievement Jonathan de Pass, chief executive of
EvaluatePharma, said: “I’m thrilled that the EP Vantage team have won the
European Mediscience 2011 Commentator of the Year award.
The life-science industry is well served for commentary by several
long-established publications and by many securities analysts so this is all
the more an incredible achievement given that EP Vantage has been going for
less than four years. After twice being runners-up for this award, this is
well-deserved recognition for the team.”
Notes for Editors:
About EP Vantage
Launched in 2007 by EvaluatePharma, EP Vantage is a daily online comment
and analysis service providing insightful, forward-looking financial
analysis of regulatory and patent decisions, marketing approvals, licensing
deals, and M&A in the biotech and pharma industry.
Written by an experienced team of journalists, EP Vantage prides itself
on covering market catalysts weeks and even months ahead of other industry
EP Vantage’s analysis is powered by EvaluatePharma, the leaders in
consensus forecasts in the pharmaceutical industry for over 12 years.
EP Vantage editorial team
Lisa Urquhart, Editor
A financial journalist for over 11 years, Lisa joined EP Vantage in 2007
as editor. Prior to this she spent seven years at the Financial Times
working in a variety of roles including Biotechnology Correspondent. During
her time at the FT Lisa generated a number of exclusives, including Barr’s
$2.2bn takeover of Pliva. Lisa has overseen the successful launch of EP
Vantage and guided its strategic development to create an award-winning
comment and analysis service. Nominated for the third consecutive year, EP
Vantage received the European MediScience Awards Commentator of the Year
award in 2011.
Amy Brown, Senior Reporter
Amy joined EP Vantage from Thomson Financial News, where she covered the
European pharmaceutical and biotechnology sectors for several years. She has
extensive experience working as a financial journalist, working for
companies including Bloomberg News, and has been a contributor to
publications such as Corporate Financier. Amy’s keen sense for news, highly
analytical mind and writing ability have all contributed to the growing
recognition and respect EP Vantage has commanded.
Christian Glennie, Senior Editorial Analyst
Christian joined EP Vantage from EvaluatePharma, where he worked as an
analyst for seven years, developing extensive and in-depth knowledge of the
pharmaceutical industry. Previously responsible for generating forecast
models for over 60 pharma and biotech companies, Christian provides analysis
and insight for EP Vantage content and is also an invaluable part of the
Jonathan Gardner, Reporter
Jonathan was previously a freelance journalist on a number of healthcare
titles including Elsevier Global Medical News. Prior to this he was
communications manager at US publication Health Affairs Journal and bureau
chief for Modern Healthcare magazine. Jonathan brings a wealth of experience
in both the US primary healthcare market and regulatory affairs to EP
Vantage, extending the reach of the publication.
About the European Mediscience Awards
The European Mediscience Awards Dinner, sponsored by Matrix, is the
largest annual gathering of quoted biotech and life sciences companies in
Europe. It celebrates the best in the sector and highlights the achievements
of individuals and companies. The event recognises the importance of access
to the capital markets to fund growth and innovation and is attended by
specialist investors, advisors, media and analysts.
Now it is 10th year, the winners were announced at a dinner which was
held at the Hotel Intercontinental, London W1 on Wednesday 22 June 2011.
Contact Lisa Urquhart EP Vantage Editor T: +44(0)20-7539-1819 E: email@example.com EP Vantage 11-29 Fashion Street London E1 6PX United Kingdom Andrew Beaven Marketing Director, EvaluatePharma Ltd T: +44(0)20-7539-1818 E: firstname.lastname@example.org EvaluatePharma Ltd 11-29 Fashion Street London E1 6PX United Kingdom
SOURCE EvaluatePharma Ltd